ALLIANCE PHARMA LS-,01 earnings per share and revenue

DVL earnings per share for the last semiannual are 0.02 EUR whereas the estimation was 0.02 EUR which accounts for -21.00% surprise. Company revenue for the same period amounts to 94.73 M EUR despite the estimated figure of 95.89 M EUR. Estimated earnings per share for the next semiannual are 0.03 EUR, and revenue is expected to reach 114.64 M EUR. Also watch annual changes over time to get a bigger picture of DVL earnings per share and revenue dynamics.